Skip to content

Lidocaine and Analgesia After Laparoscopic Cholecystectomy

Intraoperative Use of Lidocaine and Postoperative Analgesia After Laparoscopic Cholecystectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03620591
Enrollment
98
Registered
2018-08-08
Start date
2018-07-02
Completion date
2022-01-31
Last updated
2022-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Consumption, Postoperative Pain

Keywords

Lidocaine, Postoperative Pain, Opioid consumption, Laparoscopic cholecystectomy

Brief summary

The purpose of this study is to evaluate how effective is the intraoperative use of lidocaine to attenuate postoperative pain and opioids consumption after laparoscopic cholecystectomy

Detailed description

Acute postoperative pain may predict the development of chronic pain.Recently, the analgesic effect of lidocaine, as a part of a multimodal analgesia, has been evaluated in many studies. They have shown that lidocaine may have a role in the postoperative pain management, as an adjunct. Acute postoperative pain after laparoscopic cholecystectomy is complex in nature. Postoperative pain is the main complaint and the primary reason for delay discharge after laparoscopic cholecystectomy.The study includes patients undergoing laparoscopic cholecystectomy.

Interventions

DRUGLidocaine

Intraoperative administration of lidocaine

DRUGPlacebo

Intraoperative administration of normal saline

Sponsors

Larissa University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ASA physical status I-II * Age ≥ 18 years old * BMI ≤ 35

Exclusion criteria

* Allergy in local anesthetics * History of liver, kidney or heart failure * Existence of chronic pain history or daily analgesics * Psychiatric disorders * Inability to understand pain assessment

Design outcomes

Primary

MeasureTime frameDescription
Postoperative opioid consumption24 hours after the procedureThe total dose of tramadol is calculated as mg and administered intravenously.

Secondary

MeasureTime frameDescription
Incidence of Nausea and Vomiting24 hoursThe percentage of patients who had nausea and vomiting during the first 24 hours
Incidence of sedation and respiratory depression24 hoursThe percentage of patients who had sedation and respiratory depression during the first 24 hours
Incidence of shoulder pain24 hoursThe percentage of patients who had shoulder pain during the first24 hours
Incidence of headache and dizziness24 hoursThe percentage of patients who had headache and dizziness during the first 24 hours
Postoperative painDeparture of the patient from the recovery room (0hrs)Numeric Rate scale 0-10 (0=no pain to 10=worst imaginable pain)
Change from Baseline Heart RateIntraoperativeBradycardia, tachycardia during the procedure
Change in depth of anesthesiaIntraoperativeMaintenance of Bispectral index (BIS) values of 40 to 50
Side effect related to administration of lidocaine24 hoursThe percentage of patients who had tremor, dizziness, dysarthria, agitation, hallucinations and drowsiness during the first 24 hours
Change from baseline Mean Blood PressureIntraoperativeNon-invasive blood pressure measurement by using sphygmomanometer cuff

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026